🧬 RNA — Ribonucleic Acid
Structure · mRNA · rRNA · tRNA · Transcription · DNA vs RNA · Genetic Code · RNA Editing (ADAR) · RNA World Hypothesis · PYQs & MCQs
DNA vs RNA Structure. (a) Left: DNA double helix — two strands wound together, bases paired (A-T, G-C). RNA is single-stranded, contains Uracil (U) instead of Thymine (T). Key: adenine=red, thymine=yellow, guanine=purple, cytosine=green, uracil=light purple. (b) Right: RNA secondary structure — single RNA strand folding back on itself to form double-stranded regions via hydrogen bonds between complementary bases (A-U, G-C). This folding creates functional 3D shapes (hairpin loops, stem-loops) critical for tRNA and rRNA function.
RNA vs DNA — Base Difference. Left helix (RNA): contains bases C, G, A, and U (Uracil). Right helix (DNA): contains bases C, G, A, and T (Thymine). This single difference — Uracil in RNA vs Thymine in DNA — is one of the most tested UPSC facts. RNA is shown in lighter grey-green (single-stranded), DNA in darker grey (double-stranded). The free nucleotide bases floating around each helix illustrate how each nucleic acid uses its specific base set.
1. Ribose Sugar (5-carbon) — has an –OH group at 2' carbon position (DNA has –H at 2' carbon, called deoxyribose). This –OH makes RNA less stable than DNA.
2. Phosphate group — links nucleotides via phosphodiester bonds. Forms the sugar-phosphate backbone.
3. Nitrogenous Base — four types:
• Purines: Adenine (A), Guanine (G) — double ring
• Pyrimidines: Cytosine (C), Uracil (U) — single ring
(RNA uses Uracil; DNA uses Thymine — both pyrimidines)
Base pairing in RNA: A pairs with U (2 H-bonds); G pairs with C (3 H-bonds)
Single-stranded: DNA's double helix protects its bases inside the helix. RNA's single-stranded nature exposes bases to chemical attack.
Uracil vs Thymine: Thymine (5-methyluracil) resists certain mutations better than Uracil.
Why this matters: RNA's instability is actually useful — mRNA must be degraded after use (so protein production can be regulated). DNA must be stable for permanent genetic storage.
UPSC Point: RNA evolved first (RNA World), but DNA evolved later as a more stable molecule for long-term genetic storage.
Messenger RNA
Size: Variable (depends on gene)
Location: Nucleus (synthesised) → Cytoplasm (function)
Structure: Linear single strand with 5' cap, 3' poly-A tail (eukaryotes), codons
Lifespan: Short (minutes to hours) — deliberately degraded
Function:
• Carries genetic information from DNA (in nucleus) to ribosomes (in cytoplasm)
• Contains codons — triplets of nucleotides each coding for one amino acid
• Acts as the "recipe" for protein synthesis
• The full set of mRNA in a cell = Transcriptome
Key facts: Made of exons (coding) + introns (non-coding, removed by splicing). mRNA vaccine (COVID-19 — Pfizer/Moderna) uses mRNA to direct cells to make spike protein.
Ribosomal RNA
Size: Large (bacterial 16S/23S/5S; eukaryotic 18S/28S/5.8S/5S)
Location: Ribosomes (nuclear + cytoplasm)
Structure: Highly folded with complex 3D shape
Function:
• Forms the structural and functional core of ribosomes
• Combines with ribosomal proteins to form small (30S/40S) and large (50S/60S) ribosomal subunits
• Acts as a ribozyme — catalyses peptide bond formation during translation
• Controls mRNA translation into proteins
• Binds to tRNAs during translation
Key facts: Prokaryote ribosomes = 70S (30S+50S). Eukaryote = 80S (40S+60S). Mitochondria/Chloroplasts have 70S ribosomes (endosymbiotic origin). 16S rRNA used to classify bacteria (phylogenetic marker).
Transfer RNA
Size: Smallest — 73–93 nucleotides
Location: Cytoplasm
Structure: Cloverleaf (2D) → L-shaped (3D). Has anticodon loop + amino acid attachment site (3'-CCA end)
Function:
• Transfers/brings specific amino acids to the ribosome
• Contains anticodon — triplet that base-pairs with mRNA codon (complementary)
• Acts as adapter molecule — translates the nucleotide language of mRNA into amino acid language of proteins
• ~61 different tRNAs for 61 codons (3 stop codons have no tRNA)
Key facts: Aminoacyl-tRNA synthetase enzyme "charges" tRNA by attaching the correct amino acid. One tRNA can read multiple codons (wobble hypothesis).
| Feature | 📨 mRNA | ⚙ rRNA | 🚚 tRNA |
|---|---|---|---|
| % of cell RNA | ~5% | ~80% (most abundant) | ~15% |
| Size | Variable | Large (16S, 23S, 28S) | Smallest (73–93 nt) |
| Structure | Linear single strand | Highly folded complex 3D | Cloverleaf (2D) → L-shape (3D) |
| Key feature | Codons (triplets) | Forms ribosomes; is a ribozyme | Anticodon + amino acid site |
| Function | Carry DNA info to ribosome | Site of protein synthesis; catalyse peptide bonds | Bring amino acids; adapter molecule |
| Lifespan | Short (minutes–hours) | Long (stable) | Medium |
| Special name | Transcriptome = all mRNAs | Ribozyme (catalytic RNA) | Adapter molecule |
Initiation
Elongation
Termination
The RNA produced has the same sequence as the coding strand (with U instead of T).
Memory: mRNA sequence = Coding strand sequence (T→U swap). Template strand = complementary to mRNA.
miRNA (microRNA): ~22 nt, binds mRNA, blocks translation or degrades mRNA.
siRNA (small interfering RNA): ~21–23 nt, destroys target mRNA.
snRNA (small nuclear RNA): involved in splicing.
Nobel Prize 2006 (Fire & Mello) for discovering RNAi.
RNA viruses: HIV (retrovirus — RNA→DNA via reverse transcriptase), SARS-CoV-2, Influenza, Dengue, Polio, Hepatitis C.
Retroviruses: RNA → reverse transcribed to DNA → integrates into host genome.
piRNA (Piwi-interacting): protects germline genome from transposons.
circRNA (circular RNA): gene regulation, sponges miRNAs.
gRNA (guide RNA): directs CRISPR-Cas9 and ADAR to target sites.
| Feature | 🔵 DNA | 🟠 RNA |
|---|---|---|
| Full name | Deoxyribonucleic Acid | Ribonucleic Acid |
| Sugar | Deoxyribose (–H at 2' carbon) | Ribose (–OH at 2' carbon) |
| Strands | Double-stranded (mostly). Some viruses: single-stranded DNA. | Single-stranded (mostly). Some viruses: double-stranded RNA. |
| Bases | Adenine, Guanine, Cytosine, Thymine (T) | Adenine, Guanine, Cytosine, Uracil (U) |
| Base pairing | A–T (2 H-bonds), G–C (3 H-bonds) | A–U (2 H-bonds), G–C (3 H-bonds) |
| Location | Nucleus (mainly), mitochondria, chloroplasts | Nucleus + Cytoplasm (all compartments) |
| Stability | Very stable (long-term storage) | Less stable (short-term function; 2'-OH reactive) |
| Nucleotides | Up to ~4.3 billion base pairs (human genome) | Fewer; up to ~12,000 nucleotides |
| Function | Permanent genetic information storage; template for replication and transcription | Carries, transfers, catalyses during protein synthesis; gene regulation |
| Replication | Self-replicates (DNA → DNA) | Does not self-replicate (RNA viruses use RNA-dependent RNA polymerase) |
| Transcription | DNA → RNA (transcription) | RNA does not transcribe (except retroviruses: RNA → DNA by reverse transcriptase) |
| Methyl group | Thymine has methyl group at C5 (more stable than uracil) | Uracil lacks methyl group → less stable but sufficient for short-term function |
| As enzyme | DNA is NOT a catalyst | RNA CAN act as enzyme = Ribozyme (rRNA in ribosome, self-splicing introns) |
| Virus examples | Hepatitis B virus (HBV), Herpesvirus, Poxvirus, Adenovirus, Papillomavirus (HPV) | HIV, SARS-CoV-2, Influenza, Dengue, Polio, Hepatitis C, Rabies, Measles |
• Addition — insert a nucleotide
• Deletion — remove a nucleotide
• Substitution — replace one nucleotide with another (most common)
| Aspect | ✂ DNA Editing (CRISPR-Cas9) | 🧬 RNA Editing (ADAR) |
|---|---|---|
| Permanence | Permanent — alters genome forever. Irreversible if errors occur. | Temporary — RNA degraded naturally. Can stop therapy if problems arise. |
| Immune response | Cas9 protein is from bacteria → may trigger immune reaction | ADAR is naturally present in human cells → lower immune/allergic risk |
| Precision | Edits at DNA level — affects all cells derived from edited cell | Edits at mRNA level — affects only protein production, not inheritance |
| Safety concern | Off-target DNA cuts could cause mutations, cancer | Off-target RNA edits are temporary and reversible |
| Delivery | CRISPR machinery delivered via viral vectors (AAV) | Guide RNA + ADAR via lipid nanoparticles or AAV |
| Heritable? | Yes (germline editing) — ethically controversial | No — only affects somatic cells, not passed to offspring |
| Example | Sickle cell disease cure (Casgevy — first approved CRISPR therapy, 2023) | AATD treatment (WVE-006, Wave Life Sciences, 2025 — first clinical RNA editing) |
- (a) A molecular scissors used in targeted gene editing ✓
- (b) A biosensor used in the accurate detection of pathogens in patients
- (c) A gene that makes plants pest-resistant
- (d) A herbicidal substance synthesised in genetically modified crops
- (a) Fertilisation of egg in vitro by the donor sperm
- (b) Genetic modification of sperm-producing cells
- (c) Development of stem cells into functional embryos
- (d) Prevention of mitochondrial diseases in offspring ✓
- (a) Functional chromosomes can be created by joining segments of DNA taken from cells of different species. ✓ (This is NOT correct)
- (b) Pieces of artificial functional DNA can be created in laboratories.
- (c) A piece of DNA taken out from an animal cell can be made to replicate outside a living cell in a laboratory.
- (d) Cells taken out from plasma and animals can be made to undergo cell division in laboratory petri dishes.
Statement (b) CORRECT: Synthetic DNA (artificial genes, synthetic genomes) can be created — J. Craig Venter created the first synthetic bacterial cell (Mycoplasma mycoides JCVI-syn1.0, 2010) with a fully synthetic genome.
Statement (c) CORRECT: PCR (Polymerase Chain Reaction) amplifies DNA outside living cells using Taq polymerase — DNA replicates in a test tube.
Statement (d) CORRECT: Cell culture technology — human/animal cells grown in petri dishes (tissue culture, HeLa cells, primary cell cultures).
1. mRNA accounts for about 80% of total RNA in the cell and carries genetic information from DNA to ribosomes.
2. tRNA contains an anticodon that base-pairs with the mRNA codon and carries a specific amino acid to the ribosome.
3. rRNA acts as a ribozyme by catalysing the formation of peptide bonds during translation.
4. The genetic code is universal — meaning the same codon codes for the same amino acid in almost all organisms.
Which of the above statements are correct?
- (a) 1, 2 and 3 only
- (b) 1, 3 and 4 only
- (c) 2, 3 and 4 only
- (d) 1, 2, 3 and 4
Statement 2 CORRECT: tRNA (transfer RNA) has two key functional sites: (a) the anticodon loop — a triplet of bases complementary to the mRNA codon; (b) the 3'-CCA acceptor end — where the specific amino acid is covalently attached by aminoacyl-tRNA synthetase. The tRNA physically brings ("transfers") the correct amino acid to the ribosome where the anticodon-codon match ensures the right amino acid is incorporated into the growing polypeptide.
Statement 3 CORRECT: The large ribosomal subunit's rRNA (23S in prokaryotes, 28S in eukaryotes) catalyses the formation of peptide bonds between successive amino acids during translation. This was demonstrated by Thomas Steitz, Ada Yonath, and Venkatraman Ramakrishnan (shared Nobel Prize in Chemistry 2009 for ribosome structure). This confirms that rRNA is a ribozyme — a catalytic RNA molecule that acts like an enzyme.
Statement 4 CORRECT: The genetic code is nearly universal — the same codon specifies the same amino acid across bacteria, plants, animals, and fungi. For example, AUG (methionine/start codon) is universal. The few exceptions (e.g., in mitochondrial DNA where UGA codes for tryptophan instead of stop, or in some Mycoplasma species) are considered secondary modifications of the universal code. Universality is powerful evidence for the common ancestry of all life on Earth.
- (a) RNA editing permanently corrects the genetic defect at the DNA level, eliminating the need for repeated treatments, whereas CRISPR-Cas9 only temporarily fixes mRNA and requires constant reapplication.
- (b) RNA editing using ADAR makes temporary modifications to mRNA that are naturally degraded over time — allowing therapy to be stopped if side effects occur; ADAR is a naturally occurring human enzyme (lower immune risk), whereas CRISPR-Cas9 uses bacterial-derived Cas9 protein that may trigger immune reactions and causes permanent DNA changes that cannot be reversed.
- (c) RNA editing is safer because it edits both strands of the RNA double helix simultaneously, making off-target effects impossible, whereas CRISPR-Cas9 can only edit one DNA strand at a time, increasing the risk of mutations.
- (d) RNA editing is more permanent than DNA editing — once mRNA is corrected by ADAR, the correction propagates to all daughter cells during cell division, giving a one-time cure, whereas CRISPR-Cas9 effects fade within weeks.
RNA Editing (ADAR) safety advantages: (1) Reversibility: mRNA is naturally short-lived (minutes to hours). Once ADAR edits a particular mRNA molecule, that specific change exists only as long as that mRNA molecule survives. New mRNA is continuously transcribed from the (unchanged) DNA. If a therapy causes problems, it can simply be stopped — no permanent genomic alteration exists. (2) Lower immune risk: ADAR (Adenosine Deaminase Acting on RNA) is a naturally occurring enzyme in human cells. It is not a foreign bacterial protein, so the immune system is less likely to mount a reaction against it. CRISPR-Cas9 uses Cas9 from Streptococcus pyogenes — a foreign bacterial protein that can trigger immune responses, limiting repeated doses. (3) No heritable changes: Since the DNA is unaltered, RNA editing cannot be passed to offspring — avoiding the ethical concerns of germline editing.
Option (a) is wrong — it reverses the roles: DNA editing (CRISPR) is permanent; RNA editing is temporary.
Option (c) is wrong — most cellular RNA is single-stranded, not double-stranded; also, off-target effects are still possible with RNA editing.
Option (d) is wrong — RNA editing is NOT permanent and does NOT propagate to daughter cells (only DNA changes are heritable).
- (a) RNA is found in all living cells whereas DNA is only found in the nucleus, suggesting RNA is more fundamental and must have evolved first to provide instructions for the DNA that later appeared in the nucleus.
- (b) RNA is more stable than DNA because its single-stranded structure resists enzymatic degradation better than DNA's double helix, making RNA more suitable as the first genetic molecule in harsh primordial conditions.
- (c) RNA viruses are more common than DNA viruses, suggesting that RNA-based life forms were the ancestral form of all viruses, and since viruses preceded cellular life, RNA must have evolved before DNA.
- (d) RNA is uniquely capable of both storing genetic information (like DNA) AND catalysing chemical reactions as ribozymes (like proteins) — this dual functionality means a single RNA molecule could have carried out both the information storage and catalytic functions required for the origin of life, without needing either DNA or protein enzymes to already exist.
Why option (d) is correct: The fundamental problem for the origin of life is the "chicken-and-egg" paradox: DNA needs proteins to replicate; proteins need DNA for their sequence information. Neither could have existed without the other first. RNA resolves this paradox because: (a) RNA can store genetic information (sequence of bases) just like DNA. (b) RNA can catalyse chemical reactions as ribozymes — rRNA in ribosomes catalyses peptide bond formation; self-splicing introns (Group I/II) catalyse their own excision; ribozymes can replicate RNA. (c) RNA can undergo evolution (mutation + selection). A single RNA molecule could theoretically carry out all three functions — information storage, catalysis, and replication — making the origin of life possible without needing pre-existing DNA or protein enzymes.
Subsequent evolution: RNA World → RNA-protein world (RNA starts using amino acid catalysts) → DNA-RNA-protein world (DNA evolves from RNA as more stable storage molecule). The continued presence of ribozymes in modern cells (rRNA catalysing peptide bonds, snRNA in splicing, RNase P) are molecular fossils of the RNA World. Option (a) is wrong — DNA is also found in mitochondria and chloroplasts, not just the nucleus. Option (b) is wrong — RNA is LESS stable than DNA, not more. Option (c) is wrong — the relationship between viruses and cellular life is controversial; viruses are generally considered to have evolved after cellular life.
| Topic | Key Facts |
|---|---|
| Definition | Ribonucleic Acid. Polymer of ribonucleotides. Ribose sugar (not deoxyribose). Uracil (not Thymine). Mostly single-stranded. Synthesised from DNA by RNA polymerase (transcription). |
| Structure | Backbone: alternating phosphate + ribose. Bases: A, U, C, G. A–U (2 H-bonds), G–C (3 H-bonds). Secondary structure: hairpin loops, stem-loops (RNA folds on itself). Tertiary: 3D shape. 2'-OH group makes RNA less stable than DNA. |
| mRNA | ~5% of RNA (least). Carries code from DNA to ribosome. Has codons (triplets). Exons (coding) + introns (non-coding, spliced out). 5' cap + 3' poly-A tail (eukaryotes). Short-lived. Transcriptome = all mRNAs. mRNA vaccines (COVID-19 Pfizer/Moderna). |
| rRNA | ~80% of RNA (most abundant). Forms ribosomes. Prokaryote: 70S (30S + 50S); Eukaryote: 80S (40S + 60S). 16S rRNA = bacterial classification marker. Acts as ribozyme (catalyses peptide bond formation). Nobel 2009 (Steitz, Yonath, Ramakrishnan). |
| tRNA | ~15% of RNA. Smallest (73–93 nt). Cloverleaf (2D) → L-shape (3D). Anticodon base-pairs with mRNA codon. 3'-CCA end attaches amino acid. Charged by aminoacyl-tRNA synthetase. Adapter molecule. |
| Genetic Code | Triplet (3 nt = 1 amino acid). 64 codons for 20 amino acids. Degenerate/redundant (multiple codons → same amino acid). Universal (same in almost all organisms). AUG = start (Met). UAA, UAG, UGA = stop codons (no tRNA). |
| Transcription | RNA polymerase synthesises RNA from DNA template (3'→5') → RNA grows 5'→3'. Steps: Initiation (binds promoter) → Elongation (adds ribonucleotides) → Termination (reaches terminator). Eukaryote processing: 5' cap + poly-A tail + splicing (remove introns). |
| DNA vs RNA | DNA: deoxyribose, Thymine, double-stranded (mostly), stable, nucleus mainly, information storage. RNA: ribose, Uracil, single-stranded (mostly), less stable, nucleus+cytoplasm, multiple functions including catalysis. |
| RNA World | RNA was first genetic material (~4 billion years ago). RNA = information + catalyst (ribozyme). Resolves DNA-protein paradox. Evidence: ribozymes in modern cells = molecular fossils. DNA evolved later for stability. |
| RNA Editing (2025) | Wave Life Sciences: first clinical RNA editing (WVE-006) for AATD using ADAR enzymes. ADAR = Adenosine Deaminase Acting on RNA. Guide RNA (gRNA) directs ADAR to target mRNA. Temporary (RNA degrades). Safer than CRISPR: reversible, uses human enzyme (no immune reaction), not heritable. |
| RNAi | miRNA (~22 nt) — blocks/degrades mRNA. siRNA (~21–23 nt) — destroys target mRNA. Nobel 2006 (Fire & Mello). Used in gene therapy, pesticide-resistant crops. |
| RNA Viruses | Use RNA as genome. HIV = retrovirus (RNA → DNA by reverse transcriptase → integrates into host). SARS-CoV-2, Influenza, Dengue, Polio, Hepatitis C, Rabies, Measles. |
Trap 1 — "mRNA is the most abundant RNA in the cell" → WRONG! rRNA is the most abundant (~80%). mRNA is the LEAST abundant (~5%). The ranking is: rRNA (80%) > tRNA (15%) > mRNA (5%). Students confuse this because mRNA is the most discussed type. rRNA dominates because every ribosome contains multiple rRNA molecules, and thousands of ribosomes exist per cell.
Trap 2 — "UAU and UAC code for Tryptophan" → WRONG! UAU and UAC code for Tyrosine. Tryptophan has only one codon: UGG (making it the only amino acid with a single codon besides Methionine's AUG as start codon). This error actually appears in some reference texts. For UPSC: remember W = Trp = UGG (one codon); Y = Tyr = UAU/UAC (two codons).
Trap 3 — "RNA is more stable than DNA because it is single-stranded" → WRONG! RNA is LESS stable than DNA. The 2'-OH group on ribose makes RNA prone to hydrolysis. Single-strandedness exposes bases to chemical attack. This instability is actually biologically useful — mRNA must be degraded after use so protein production can be tightly regulated. DNA evolved later precisely because it is more stable for long-term genetic storage.
Trap 4 — "tRNA contains codons; mRNA contains anticodons" → WRONG! (roles swapped) mRNA contains CODONS; tRNA contains ANTICODONS. mRNA codons (5'→3') are read by ribosome. tRNA anticodon is complementary and antiparallel to mRNA codon — the tRNA anticodon base-pairs with the mRNA codon to bring the correct amino acid. Memory: mRNA = message with Codons; tRNA = transporter with Anticodon (Anti = opposite/against the codon).
Trap 5 — "RNA editing (ADAR) permanently corrects the disease-causing mutation in DNA" → WRONG! RNA editing only modifies mRNA — not the underlying DNA. The genetic mutation in DNA remains unchanged. This is why RNA editing requires repeated treatments (new mRNA is continuously made from the mutated DNA). The advantage is reversibility and safety — not permanence. DNA editing (CRISPR-Cas9) corrects the actual DNA mutation permanently but carries risks of irreversible errors.


